cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccrl0dq
title: CCDC 702503: Experimental Crystal Structure Determination

description: Related Article: Su-Qing Wang, Fang-Fang Jian, Huan-Qiang Liu|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1750|doi:10.1107/S1600536808025154
DOI: 10.5517/ccrl0fr
title: CCDC 702504: Experimental Crystal Structure Determination

description: Related Article: Yun-Hua Xu, Fanqi Qu|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1751|doi:10.1107/S1600536808025130
DOI: 10.5517/ccrl0gs
title: CCDC 702505: Experimental Crystal Structure Determination

description: Related Article: Yong-Tao Wang, Gui-Mei Tang, Yong-Chun Zhang, Wen-Zhu Wan|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1753|doi:10.1107/S1600536808025567
DOI: 10.5517/ccrl0ht
title: CCDC 702506: Experimental Crystal Structure Determination

description: Related Article: Yong-Tao Wang, Gui-Mei Tang, Wen-Zhu Wan|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1754|doi:10.1107/S1600536808025555
DOI: 10.5517/ccrl0jv
title: CCDC 702507: Experimental Crystal Structure Determination

description: Related Article: Jian Wei, Guang Liang, Yuhong Gai, Jingmei Lu|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1755|doi:10.1107/S1600536808025543
DOI: 10.5517/ccrl0kw
title: CCDC 702508: Experimental Crystal Structure Determination

description: Related Article: Yin-hong Liu, Fang-shi Li, Yi Li|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1756|doi:10.1107/S1600536808025506
DOI: 10.5517/ccrl0p0
title: CCDC 702512: Experimental Crystal Structure Determination

description: Related Article: G.Ramachandran, C.C.Kanakam, B.Gunasekaran, V.Manivannan|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1760|doi:10.1107/S1600536808025749
DOI: 10.5517/ccrl0q1
title: CCDC 702513: Experimental Crystal Structure Determination

description: Related Article: H.D.Choi, P.J.Seo, B.W.Son, U.Lee|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1761|doi:10.1107/S1600536808025786
DOI: 10.5517/ccrl0r2
title: CCDC 702514: Experimental Crystal Structure Determination

description: Related Article: M.Ramos Silva, J.A.Silva, N.D.Martins, A.Matos Beja, A.J.F.N.Sobral|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1762|doi:10.1107/S1600536808025658
DOI: 10.5517/ccrl0s3
title: CCDC 702515: Experimental Crystal Structure Determination

description: Related Article: E.Yang, Xu-Chun Song, Rong-Qiang Zhuang|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1763|doi:10.1107/S1600536808025300
DOI: 10.5517/ccrl0t4
title: CCDC 702516: Experimental Crystal Structure Determination

description: Related Article: E.Yang, Xu-Chun Song, Jian-Wei Zhu|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1764|doi:10.1107/S1600536808025312
DOI: 10.5517/ccrl0x7
title: CCDC 702519: Experimental Crystal Structure Determination

description: Related Article: A.Hasan, S.Ikram, A.Badshah, M.Bolte, M.Zia|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1767|doi:10.1107/S1600536808025725
DOI: 10.5517/ccrl0y8
title: CCDC 702520: Experimental Crystal Structure Determination

description: Related Article: Chun-Sheng Zhang, Da-Xiong Li, De-Hua Zhang, Yan-Ping He, Cong Li|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1768|doi:10.1107/S1600536808025592
DOI: 10.5517/ccrl0z9
title: CCDC 702521: Experimental Crystal Structure Determination

description: Related Article: M.Laila, H.M.Ali, S.Puvaneswary, W.T.Robinson, S.W.Ng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1769|doi:10.1107/S1600536808025932
DOI: 10.5517/ccrl10c
title: CCDC 702522: Experimental Crystal Structure Determination

description: Related Article: S.Mansor, N.Zakaria, A.Ariffin, S.W.Ng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1770|doi:10.1107/S1600536808025920
DOI: 10.5517/ccrl11d
title: CCDC 702523: Experimental Crystal Structure Determination

description: Related Article: A.D.Khalaji, S.W.Ng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1771|doi:10.1107/S1600536808025919
DOI: 10.5517/ccrl12f
title: CCDC 702524: Experimental Crystal Structure Determination

description: Related Article: Ling-Ling Zhao, Da Teng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1772|doi:10.1107/S1600536808025695
DOI: 10.6084/m9.figshare.13360380
title: Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease

description: There is a need for easy-to-use patient-reported outcome measures (PROMS) in inflammatory bowel disease (IBD) practice. The ‘IBD-control’ is a short IBD-specific questionnaire capturing disease control from the patient’s perspective. The International Consortium for Health Outcomes Measurement (ICHOM) recommends the use of the IBD-control even though it has only been validated in the United Kingdom. We aimed to cross-culturally translate and validate the IBD-control in the Netherlands using IBDREAM, a prospective multicentre IBD registry. Lack of ambiguity and acceptability were verified in a pilot patient group (<i>n</i> = 5) after forward-backward translation of the IBD-control. Prospective validation involved completion of the IBD-control, Short Form-36, short IBDQ and disease activity measurement by Physician Global Assessment (PGA) and Simple Clinical Colitis Activity Index or Harvey-Bradshaw Index. Test–retest (2-week repeat) was used for measuring reliability. Questionnaires were completed by 998 IBD patients (674 Crohn’s disease, 324 ulcerative colitis). Internal consistency (Cronbach’s alpha) was 0.82 for the sub-group of 8 questions (IBD-control-8-sub-score). Mean completion time was 105 s. Construct validity analyses demonstrated moderate-to-strong correlations of the IBD-control-8-subscore and the other instruments (0.49-0.81). Test–retest reliability for stable patients was high (intraclass correlation coefficient 0.95). The IBD-control-8-subscore showed good discriminant ability between the PGA categories (ANOVA, <i>p</i> These results support the IBD-control as a rapid, reliable, valid and sensitive instrument for measuring disease control from an IBD patient’s perspective in the Netherlands.
DOI: 10.6084/m9.figshare.13360380.v1
title: Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease

description: There is a need for easy-to-use patient-reported outcome measures (PROMS) in inflammatory bowel disease (IBD) practice. The ‘IBD-control’ is a short IBD-specific questionnaire capturing disease control from the patient’s perspective. The International Consortium for Health Outcomes Measurement (ICHOM) recommends the use of the IBD-control even though it has only been validated in the United Kingdom. We aimed to cross-culturally translate and validate the IBD-control in the Netherlands using IBDREAM, a prospective multicentre IBD registry. Lack of ambiguity and acceptability were verified in a pilot patient group (<i>n</i> = 5) after forward-backward translation of the IBD-control. Prospective validation involved completion of the IBD-control, Short Form-36, short IBDQ and disease activity measurement by Physician Global Assessment (PGA) and Simple Clinical Colitis Activity Index or Harvey-Bradshaw Index. Test–retest (2-week repeat) was used for measuring reliability. Questionnaires were completed by 998 IBD patients (674 Crohn’s disease, 324 ulcerative colitis). Internal consistency (Cronbach’s alpha) was 0.82 for the sub-group of 8 questions (IBD-control-8-sub-score). Mean completion time was 105 s. Construct validity analyses demonstrated moderate-to-strong correlations of the IBD-control-8-subscore and the other instruments (0.49-0.81). Test–retest reliability for stable patients was high (intraclass correlation coefficient 0.95). The IBD-control-8-subscore showed good discriminant ability between the PGA categories (ANOVA, <i>p</i> These results support the IBD-control as a rapid, reliable, valid and sensitive instrument for measuring disease control from an IBD patient’s perspective in the Netherlands.
DOI: 10.5281/zenodo.4682170
title: Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid

description: Detection of Neoplasms by Metagenomic Sequencing of Cerebrospinal Fluid Wei Gu<sup>1,2</sup>*, Andreas M. Rauschecker<sup>3</sup>, Elaine Hsu<sup>1</sup>, Kelsey C. Zorn<sup>4</sup>, Yasemin Sucu<sup>1</sup>, Scot Federman<sup>1</sup>, Allan Gopez<sup>1</sup>, Shaun Arevalo<sup>1</sup>, Hannah A. Sample<sup>4</sup>, Eric Talevich<sup>5</sup>, Eric D. Nguyen<sup>1</sup>, Marc Gottschall<sup>1</sup>, Carl A. Gold<sup>6</sup>, Bruce A.C. Cree<sup>7</sup>, Vanja Douglas<sup>7</sup>, Megan B. Richie<sup>7</sup>, Maulik P. Shah<sup>7</sup>, S. Andrew Josephson<sup>7</sup>, Jeffrey M. Gelfand<sup>7</sup>, Steve Miller<sup>1</sup>, Linlin Wang<sup>1</sup>, Tarik Tihan<sup>8</sup>, Joseph L. DeRisi<sup>4,9</sup>, Charles Y. Chiu<sup>10,11</sup>, Michael R. Wilson<sup>7</sup>* <sup>1</sup>Department of Laboratory Medicine, University of California San Francisco, CA 94107, USA <sup>2</sup>Department of Pathology, Stanford University, CA 94305, USA <sup>3</sup>Department of Radiology and Biomedical Imaging, University of California San Francisco, CA 94107, USA <sup>4</sup>Department of Biochemistry and Biophysics, University of California San Francisco, CA 94107, USA <sup>5</sup>DNANexus, Mountain View, CA 94040, USA <sup>6</sup>Department of Neurology, Stanford University, CA 94305, USA <sup>7</sup>Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, CA 94107, USA <sup>8</sup>Department of Pathology, University of California San Francisco, CA 94107, USA <sup>9</sup>Chan Zuckerberg Biohub, San Francisco, CA 94107, USA <sup>10</sup>UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA 91407, USA <sup>11</sup>Department of Medicine, Division of Infectious Diseases, University of California San Francisco, CA 94107, USA * Corresponding authors: Michael Wilson Michael.Wilson@ucsf.edu, Wei Gu weigu@stanford.edu
DOI: 10.6084/m9.figshare.13194092.v1
title: Association of tibolone and dementia risk: a cohort study using Korean claims data

description: Few studies have examined whether tibolone (TIB), a type of hormone replacement therapy widely used in Asia and Europe, affects dementia risk in postmenopausal women. Our study aims to investigate the association of TIB and dementia risk in Korean women aged 50–80 years. A population-based longitudinal study was conducted using the Korean National Health Insurance Service claims database merged with national health examination data from 2002 to 2015. Among 13,110 participants, exposure to TIB was determined using the standardized defined daily dose (DDD) system from 2003 to 2007. Starting from 2007, participants were followed up for overall dementia, Alzheimer’s disease (AD) and vascular dementia (VD) until 2015. Cox proportional hazards regression was used to determine the adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of dementia according to TIB use. TIB use was not significantly associated with the risk of total dementia (aHR = 1.040; 95% CI = 0.734–1.472; <i>p</i> = .827), AD (aHR = 0.949; 95% CI = 0.652–1.381; <i>p</i> = .785) and VD (aHR = 1.245; 95% CI = 0.631–2.457; <i>p</i> = .528). Our results suggest that TIB use does not have a significant association with dementia risk. Further randomized controlled trials are necessary to elucidate the role of exogenous hormones in the development of dementia.
DOI: 10.6084/m9.figshare.13194092
title: Association of tibolone and dementia risk: a cohort study using Korean claims data

description: Few studies have examined whether tibolone (TIB), a type of hormone replacement therapy widely used in Asia and Europe, affects dementia risk in postmenopausal women. Our study aims to investigate the association of TIB and dementia risk in Korean women aged 50–80 years. A population-based longitudinal study was conducted using the Korean National Health Insurance Service claims database merged with national health examination data from 2002 to 2015. Among 13,110 participants, exposure to TIB was determined using the standardized defined daily dose (DDD) system from 2003 to 2007. Starting from 2007, participants were followed up for overall dementia, Alzheimer’s disease (AD) and vascular dementia (VD) until 2015. Cox proportional hazards regression was used to determine the adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of dementia according to TIB use. TIB use was not significantly associated with the risk of total dementia (aHR = 1.040; 95% CI = 0.734–1.472; <i>p</i> = .827), AD (aHR = 0.949; 95% CI = 0.652–1.381; <i>p</i> = .785) and VD (aHR = 1.245; 95% CI = 0.631–2.457; <i>p</i> = .528). Our results suggest that TIB use does not have a significant association with dementia risk. Further randomized controlled trials are necessary to elucidate the role of exogenous hormones in the development of dementia.
DOI: 10.6084/m9.figshare.12477860.v1
title: White, brown, and bone marrow adipose tissue behavior in DHEA-induced PCOS mice

description: <b>Introduction: </b>To investigate the behavior of white, brown, and bone marrow adipose tissue (MAT) and the insulin resistance in a PCOS mice model. Thirty-one female C57BL/6J mice were divided into four groups: two were treated with subcutaneous dehydroepiandrosterone (DHEA) implants and divided into normal and hypercaloric diet (HFD). Two were control and divided into normal and HFD. Presence of insulin resistance, growth, and adipocyte markers expression of white and brown adipose tissues and growth and inflammatory cytokines expression of bone marrow adipose tissue were evaluated. Hypercaloric diet groups presented higher total weight gain and huge growth in all fat sites, except bone marrow. They also demonstrated greater expression of adipocyte markers in sites of white adipose tissue. DHEA + HFD group showed more insulin intolerance than all other groups. DHEA shows to abrogate Adipo<i>Q</i> expression in all fatty tissues. DHEA alone does not influence adipose tissue growth, but contributes to increased insulin resistance and influences the expression of adipokines. Proximal MAT showed different behavior from the other fat depot.
DOI: 10.6084/m9.figshare.12887875
title: The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy

description: Women with history of breast cancer (HBC) frequently suffer from vulvovaginal atrophy (VVA). European Vulvovaginal Epidemiology Survey (EVES) sub-analysis assesses the impact of HBC on VVA, sexual life and quality of life (QoL) in postmenopausal women. Women with at least one VVA symptom aged 45–75 years were included. EuroQol (EQ-5D-3L) and Day-to-Day Impact of Vaginal Aging (DIVA) questionnaires were filled to investigate QoL. VVA diagnosis was confirmed with objective gynecological examination. Comparison of postmenopausal women with and without HBC, and evaluation of treatment impact on VVA were performed. 1985 postmenopausal women without HBC and 175 with HBC were included. VVA was confirmed in 90.4% of women without HBC and 91.4% of women with HBC. There were no differences in VVA symptoms severity or vulvovaginal discomfort between groups. However, women with HBC who had completed treatment and had surgery 11–20 years previously versus those without HBC presented significantly worse Vaginal Health Index scores, as well as a higher prevalence of VVA objective diagnosis, although their overall symptom severity score was lower. Health status and QoL comparisons were similar. Results support a similar burden in terms of VVA prevalence and symptoms, QoL and sexual function in postmenopausal women with and without HBC.
DOI: 10.6084/m9.figshare.12887875.v1
title: The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy

description: Women with history of breast cancer (HBC) frequently suffer from vulvovaginal atrophy (VVA). European Vulvovaginal Epidemiology Survey (EVES) sub-analysis assesses the impact of HBC on VVA, sexual life and quality of life (QoL) in postmenopausal women. Women with at least one VVA symptom aged 45–75 years were included. EuroQol (EQ-5D-3L) and Day-to-Day Impact of Vaginal Aging (DIVA) questionnaires were filled to investigate QoL. VVA diagnosis was confirmed with objective gynecological examination. Comparison of postmenopausal women with and without HBC, and evaluation of treatment impact on VVA were performed. 1985 postmenopausal women without HBC and 175 with HBC were included. VVA was confirmed in 90.4% of women without HBC and 91.4% of women with HBC. There were no differences in VVA symptoms severity or vulvovaginal discomfort between groups. However, women with HBC who had completed treatment and had surgery 11–20 years previously versus those without HBC presented significantly worse Vaginal Health Index scores, as well as a higher prevalence of VVA objective diagnosis, although their overall symptom severity score was lower. Health status and QoL comparisons were similar. Results support a similar burden in terms of VVA prevalence and symptoms, QoL and sexual function in postmenopausal women with and without HBC.
DOI: 10.6084/m9.figshare.12477860
title: White, brown, and bone marrow adipose tissue behavior in DHEA-induced PCOS mice

description: <b>Introduction: </b>To investigate the behavior of white, brown, and bone marrow adipose tissue (MAT) and the insulin resistance in a PCOS mice model. Thirty-one female C57BL/6J mice were divided into four groups: two were treated with subcutaneous dehydroepiandrosterone (DHEA) implants and divided into normal and hypercaloric diet (HFD). Two were control and divided into normal and HFD. Presence of insulin resistance, growth, and adipocyte markers expression of white and brown adipose tissues and growth and inflammatory cytokines expression of bone marrow adipose tissue were evaluated. Hypercaloric diet groups presented higher total weight gain and huge growth in all fat sites, except bone marrow. They also demonstrated greater expression of adipocyte markers in sites of white adipose tissue. DHEA + HFD group showed more insulin intolerance than all other groups. DHEA shows to abrogate Adipo<i>Q</i> expression in all fatty tissues. DHEA alone does not influence adipose tissue growth, but contributes to increased insulin resistance and influences the expression of adipokines. Proximal MAT showed different behavior from the other fat depot.
DOI: 10.21227/tr3w-px39
title: Optimal Service Restoration in Active Distribution Networks Considering Microgrid Formation and Voltage Control Devices: Test Data

description: Data for the 53-node system used for optimal service restoration in active distribution networks considering microgrid formation and voltage control devices.
DOI: 10.5517/ccrl13g
title: CCDC 702525: Experimental Crystal Structure Determination

description: Related Article: S.Nirmala, R.Murugan, E.T.S.Kamala, L.Sudha, S.S.Narayanan|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1774|doi:10.1107/S1600536808025774
DOI: 10.5517/ccrl14h
title: CCDC 702526: Experimental Crystal Structure Determination

description: Related Article: S.Puvaneswary, H.M.Ali, W.T.Robinson, S.W.Ng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1777|doi:10.1107/S1600536808026044
DOI: 10.5517/ccrl15j
title: CCDC 702527: Experimental Crystal Structure Determination

description: Related Article: S.Mansor, W.A.Yehye, A.Ariffin, N.A.Rahman, S.W.Ng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1778|doi:10.1107/S1600536808026056
DOI: 10.5517/ccrl16k
title: CCDC 702528: Experimental Crystal Structure Determination

description: Related Article: Guo-wei Gao, Xiao-yan Ma, Yan Jiang, Wei Chen, Jian Men|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1779|doi:10.1107/S1600536808025762
DOI: 10.5517/ccrl17l
title: CCDC 702529: Experimental Crystal Structure Determination

description: Related Article: Hai-Tang Du, Hai-Jun Du, Weiyi Zhou|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1780|doi:10.1107/S1600536808026299
DOI: 10.5517/ccrl18m
title: CCDC 702530: Experimental Crystal Structure Determination

description: Related Article: K.Baranowska, N.Piwowarska|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1781|doi:10.1107/S1600536808025877
DOI: 10.5517/ccrl19n
title: CCDC 702531: Experimental Crystal Structure Determination

description: Related Article: Su-Qing Wang, Fang-Fang Jian, Huan-Qiang Liu|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1782|doi:10.1107/S160053680802610X
DOI: 10.5517/ccrl1cq
title: CCDC 702533: Experimental Crystal Structure Determination

description: Related Article: V.Aburto-Luna, R.-L.Meza-Leon, S.Bernes|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1784|doi:10.1107/S1600536808026196
DOI: 10.5517/ccrl1dr
title: CCDC 702534: Experimental Crystal Structure Determination

description: Related Article: A.Djedouani, S.Boufas, M.Allain, G.Bouet, M.Khan|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1785|doi:10.1107/S1600536808026032
DOI: 10.5517/ccrl1kx
title: CCDC 702539: Experimental Crystal Structure Determination

description: Related Article: H.-K.Fun, R.Kia, V.Mirkhani, H.Zargoshi|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1790|doi:10.1107/S1600536808026305
DOI: 10.5517/ccrl1ly
title: CCDC 702540: Experimental Crystal Structure Determination

description: Related Article: Xiao-Yan Ren, Fang-Fang Jian|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1792|doi:10.1107/S1600536808026123
DOI: 10.5517/ccrl1mz
title: CCDC 702541: Experimental Crystal Structure Determination

description: Related Article: Xiao-Yan Ren, Yu-Feng Ding, Fang-Fang Jian|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1793|doi:10.1107/S1600536808026111
DOI: 10.5517/ccrl1n0
title: CCDC 702542: Experimental Crystal Structure Determination

description: Related Article: Jiu-Si Wang, Yan-Ling Jiang, Wen-Kui Dong, Li Xu, Ai-Ping Kong|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1794|doi:10.1107/S1600536808026263
DOI: 10.5517/ccrl1p1
title: CCDC 702543: Experimental Crystal Structure Determination

description: Related Article: P.-H.Ma, X.Xiao, Y.-Q.Zhang, S.-F.Xue, Z.Tao|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1795|doi:10.1107/S160053680802429X
DOI: 10.5517/ccrl1q2
title: CCDC 702544: Experimental Crystal Structure Determination

description: Related Article: R.P.Nikolova, T.Kolev, S.M.Statkova-Abeghe, B.L.Shivachev|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1796|doi:10.1107/S1600536808026020
DOI: 10.5517/ccrl1r3
title: CCDC 702545: Experimental Crystal Structure Determination

description: Related Article: K.-X.Zhu, D.C.Craig, A.C.Try|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1797|doi:10.1107/S1600536808026226
DOI: 10.5517/ccrl1s4
title: CCDC 702546: Experimental Crystal Structure Determination

description: Related Article: Kong Mun Lo, Seik Weng Ng|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1798|doi:10.1107/S1600536808026214
DOI: 10.5517/ccrkzfp
title: CCDC 702473: Experimental Crystal Structure Determination

description: Related Article: S.F.Jenkinson, K.V.Booth, P.Gullapalli, K.Morimoto, K.Izumori, G.W.J.Fleet, D.J.Watkin|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1705|doi:10.1107/S1600536808024586
DOI: 10.5517/ccrkzjs
title: CCDC 702476: Experimental Crystal Structure Determination

description: Related Article: P.Parthiban, V.Ramkumar, H.D.Santan, J.T.Kim, Y.T.Jeong|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1710|doi:10.1107/S1600536808024744
DOI: 10.5517/ccqt3h3
title: CCDC 679535: Experimental Crystal Structure Determination

description: Related Article: M.N.Mohideen, A.Rasheeth, C.A.M.A.Huq, S.S.Nizar|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1752|doi:10.1107/S1600536808025610
DOI: 10.5517/ccrl0v5
title: CCDC 702517: Experimental Crystal Structure Determination

description: Related Article: Q.-C.Huang, B.-G.Li, Y.-P.Xie, K.-B.Yu, G.-L.Zhang|2008|Acta Crystallogr.,Sect.E:Struct.Rep.Online|64|o1765|doi:10.1107/S1600536808025737